Compliance certificate Under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare Ltd (formerly Kapil Cotex Ltd) has submitted the quarterly compliance certificate from its Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt. Ltd., under SEBI's Regulation 74(5) for the quarter ended 31 December 2025. The certificate confirms that physical share certificates received for dematerialisation (if any) have been duly verified, mutilated, cancelled, and the depository's name substituted as registered owner. However, the RTA noted that no physical share certificates were actually received for demat during this quarter. The filing is dated 16 January 2026 and signed by Director Prakashchandra Rathi.
This is a routine, procedural regulatory filing with no material business or financial impact on shareholders. It simply confirms compliance with SEBI's dematerialisation rules and signals that no physical-to-demat conversions occurred during the quarter, reflecting the already-dematerialised status of the company's shares.